Joined Cases T-221/22 and T-242/22: Judgment of the General Court of 20 December 2023 — Pharmaselect International and OmniActive Health Technologies v EUIPO — OmniActive Health Technologies and Pharmaselect International (LUTAMAX) (EU trade mark — Revocation proceedings — EU word mark LUTAMAX — Genuine use of the mark — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001) — Obligation to state reasons — Article 94(1) of Regulation 2017/1001)